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Mitochondrial dysfunction is pervasive in human pathologies such as 
neurodegeneration, diabetes, cancer and pathogen infections as well as during 
normal aging. Cells sense and respond to mitochondrial stress or dysfunction 
by activating a protective transcriptional program known as the mitochondrial 
unfolded protein response (UPRmt), which includes genes that promote 
mitochondrial protein homeostasis and the regeneration of metabolically 
defective organelles (Nargund, Pellegrino et al. 2012, Nargund, Fiorese et al. 
2015). Work in C. elegans has shown that the UPRmt is regulated by the 
transcription factor ATFS-1, which is regulated by organelle partitioning. 
Normally, ATFS-1 accumulates within mitochondria, but during respiratory chain 
dysfunction, high levels of ROS or mitochondrial protein folding stress, a 
percentage of ATFS-1 accumulates in the cytosol and traffics to the nucleus 
where it activates the UPRmt (Nargund, Pellegrino et al. 2012). While similar 
transcriptional responses have been described in mammals (Zhao, Wang et al. 
2002, Wu, Williams et al. 2014), how the UPRmt is regulated remains unclear. 
Here, we describe a mammalian transcription factor, ATF5, which is regulated 
similarly to ATFS-1 and induces a similar transcriptional response. ATF5 
expression can rescue UPRmt signaling in atfs-1-deficient worms requiring the 
same UPRmt promoter element identified in C. elegans. Furthermore, 
mammalian cells require ATF5 to maintain mitochondrial activity during 
mitochondrial stress and to promote organelle recovery. Combined, these data 
suggest that regulation of the UPRmt is conserved from worms to mammals.  
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Chapter 1. Introduction 
 
1.1 The Mitochondrion: The Seed of the tree Eucarya 
 
Mitochondria are organelles descended from an endosymbioitic α-
proteobacteria that was engulfed by pre-eukaryotic cells (Allen 2003, Lane and 
Martin 2010, Gray 2012). This engulfment event allowed energy production to 
be specialized to one area of the cell and contributed to the explosion of 
multicellular complexity found only in eukaryotic cells. Because of this 
contribution, the mitochondrion is primarily associated with energy production; 
however, it also serves important roles for production of essential metabolites 
and co-factors such as fatty acids, amino acids, and iron-sulfur clusters (Lill and 
Mühlenhoff 2008, Osman, Voelker et al. 2011, Wellen and Thompson 2012) 
and a signaling platform that is central in the activation of apoptosis and innate 
immunity (Zhao, Wang et al. 2002, Weinberg, Sena et al. 2015). Because of 
these diverse functions, the preservation of mitochondria homeostasis is 
centrally important to cellular and organismal health. Failure to maintain 
mitochondrial function results in a diverse array of diseases, from Parkinson’s 
disease to various cancers (Nunnari and Suomalainen 2012, Vafai and Mootha 
2012). 
The central role mitochondria play in many cellular functions is in agreement 
with recent evidence that endosymbiosis is what drove the evolution of 
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eukaryotic cells (Martin and Muller 1998, Gray 2012). This model, known as 
symbiogenesis or the “hydrogen hypothesis” (Martin and Muller 1998) states 
that the engulfment of a eubacteria from the Alphaproteobacteria family by a 
host cell, likely from the Archean family came before all other features we 
associate with a eukaryotic cell. This theory has supplanted the classical theory 
of eukaryotic evolution, known as the “archezoan scenario” which held that 
eukaryotic cells were essentially developed before the endosymbiosis event 
(Margulis 1970), derived from the mistaken idea that some protists evolved 
without a discernable endosymbiont, the so-called “early-branching” eukaryotes 
(Embley and Hirt 1998). This revised timetable puts mitochondria in a leading 
role in the evolution of all eukaryotic cells, paving the way for the development 
of other features of the eukaryotic cell, such as a nucleus and further 
compartmentalization of the cell. The question now becomes: what makes 
mitochondria so special in contrast to the other features of the eukaryotic cell? 
The key to the specialization of mitochondria is that they contain their own DNA, 
evidence of their endosymbiotic origins. Over time the genome of the 
mitochondria has had genes transferred to the nucleus or lost genes altogether 
(Gray 1999, Timmis, Ayliffe et al. 2004), which allowed mitochondria to become 
specialized for energy production, a phenomenon that is pronounced in 
multicellular eukaryotes. Animal mitochondria are gene-poor containing on 
average 40 genes, compared to protist mitochondria, some of which hold 100 
genes (Burger, Gray et al. 2003). This shortening of the genome results in a 
 3 
quicker replication time, making dynamic adjustments in the capacity of energy 
production easier. Mitochondria contain about 2-10 genomes per mitochondrion 
(Wiesner, Ruegg et al. 1992), and energy production of individual 
mitochondrion is tied to the transcriptional activity of local mitochondria DNA 
(mtDNA) (Williams 1986). Among the benefits of a specialized genome is more 
energy production per megabase of genetic information, which enables the cell 
to develop a genome with more complexity, such as non-coding regulatory 
regions, introns, and intergenic regions (Martin and Koonin 2006, Lane and 
Martin 2010). For example, note the greater density per Mb of genes found in 
prokaryotes, which have no specialized genome for energy production, versus 
those of mitochondria-containing animal cells (Lane and Martin 2010). Thus, the 
development of mitochondria enabled the eukaryotic genome to achieve the 
intricacy necessary to sustain complex organisms, and indeed is necessary to 
sustain the function of those organisms. In short, the presence of mitochondria 
in the eukaryotic cell allows the cell to increase the yield of energy per base pair 
and also dynamically adjust to energy requirements of the cell. It also raised a 
new problem for the cell: the coordination of nuclear and mitochondrial 
genomes for gene expression. 
1.2 Energy production in mitochondria: a dance of two genomes 
 
Although the mitochondrial genome is small in animals, about 16 kilobases in 
mammals, with a small number of genes encoded therein: 13 protein-coding, 22 
tRNA, and 2 rRNA genes. In animal mtDNA, there is a core of gene products 
 4 
always present that encodes components of the ETC and ATP synthase that 
produces the majority of energy for the cell (Figure 1.1). Transcription is 
polycistronic, producing two transcripts known as the heavy and light strands. 
This is due to the difference in density on a cesium chloride gradient caused by 
the high guanine content of the heavy strand while the light strand is relatively 
guanine poor (Falkenberg, Larsson et al. 2007).  
The mitochondrial DNA encodes components for the ETC and ATP synthase, 
which are vitally important for the energy-producing capabilities of the 
mitochondrion. The ETC and ATP synthase combine to produce energy in a 
process known as oxidative phosphorylation (OXPHOS). This process takes 
fuel molecules and transfers their electrons to nicotinamide (NAD) or flavine 
adenine (FAD) through glycolysis, the tricaboxylic acid (TCA) cycle, and β-
oxidation. NAD and FAD are then oxidized through the ETC. The ETC is 
comprised of four complexes, termed I-IV. Complexes I, III, and IV generate 
proton force pumping protons out of the matrix into the intermembrane space, 
aided by complex II and the electron transfer cofactors ubiquinone and 
cytochrome c. Proton translocation back into the matrix is then facilitated by 
ATP synthase which couples the proton translocation with ATP synthesis 
(Ghezzi and Zeviani 2012). Complex I is the largest of the ETC, a holoenzyme 
approximately 980 kDa in size. Complex I is comprised of 45 proteins total, with 
39 being encoded by the nuclear genome and 7 being encoded by the 
mitochondrial DNA (Giachin, Bouverot et al. 2016). The complex takes the form 
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of an “L” shape, with the peripheral arm protruding into the matrix and 
catalyzing the electron transport function of the complex. The membrane 
integrated module handles the proton transport of the holoenzyme, and 40% f 
the proton motive force required for ATP synthesis is produced by complex I. 
The two functions are linked, as the oxidation of NADH to NAD+  and transport 
of the electrons to ubqiuinone facilitates the transport of 4 protons from the 
matrix to the IMS. Interestingly, all seven of the mtDNA encoded complex I 
genes are components of this membrane domain (Vinothkumar, Zhu et al. 
2014). The mitochondrial DNA components play a crucial role in complex I 
assembly. For example, it has been shown that the ND5 subunit encoded by 
mtDNA is rate-limiting step for assembly of complex I of the ETC (Bai, Shakeley 
et al. 2000).  However, it remains unknown exactly why the cell does not simply 
have all the information for the building of multi-subunit complex all in one 
place, and rather the information be separate on two genomes, a seemingly 
unnecessary convoluted arrangement. While several theories have been 
proposed, from the idea that gene transfer between the mitochondrion and 
nucleus is ongoing, to the observation that the remaining genes in 
mitochondrion may be too hydrophobic to translate outside of the organelle, 
there remains little evidence for any one theory over the others (Allen 2003). 
Another possibility is the co-location of redox regulation (CORR) hypothesis. 
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Figure 1.1  Human Mitochondrial DNA Map and Electron Transport Chain 
(A) Map of human mitochondrial DNA showing non-coding regions (gray) and 
genes punctuated by tRNA genes (white) complex I (NADH dehydrogenase) 
genes (orange), complex III (cytochrome bc1 complex) genes (green), complex IV 
(cytochrome c oxidase) genes (yellow), and complex V (ATP synthase) genes 
(purple). Corresponding electron transport chain complexes are matched in (B) 
with proton flow shown in black, and electron transport shown in red. Adapted 
from (Chial and Craig 2008) 
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The CORR hypothesis states that the nucleus is unable to respond to changes 
in O2 rapidly enough, and therefore genes whose gene products can respond 
to O2 changes through redox regulation have been retained in the 
mitochondria. While this hypothesis remains to be tested, this would explain the 
logic of splitting the information to build the respiratory chain into two genomes, 
as well as why the mtDNA always carry a core of genes that encode for the 
ETC and ATP synthase. This core of genes is involved with directly transporting 
electrons and would be able to sense changes in O2 concentration before any 
other system in the cell (Allen 2003). As we shall see later, this ability to detect 
oxygen concentration changes in the cell makes the mitochondria ideal for 
monitoring the overall health of the cell, a sort of canary in the coalmine for 
cellular homeostasis.  
As attractive as the CORR hypothesis may be, there are many counter 
arguments to it that of varying plausibility. Amongst these hypotheses is the so-
called “lock-in” theory, whereby certain genes must be expressed in the 
mitochondrion to direct the other components to the organelle to maintain 
proper localization of the respiratory complex to the mitochondria (Bogorad 
1975). Another argument is that the gene transfer of mitochondrial genes to the 
nucleus is still in progress and has not yet been completed (Palmer 1997). 
Another hypothesis that does not necessarily contrast with the CORR 
hypothesis is the “hydrophobicity hypothesis”. This argument holds that a 
common feature of mtDNA encoded proteins is that they are hydrophobic. The 
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reason for this is that the proteins are simply too hydrophobic to be synthesized 
and imported in the cytosol and so must be made in the mitochondrial 
compartment(Beaudoin, Vachereau et al. 1986) In any case, having a 
cytoplasmic genome has necessitated the development of a cytoplasmic 
genetic system that is quite unlike the nuclear genetic system in many ways. 
1.3 Mitochondria: From Replication to Protein Synthesis 
Mammalian mitochondrial DNA genetics are quite different from those of 
nuclear DNA genetics. As opposed to the two copies of nuclear DNA present in 
every cell, mitochondrial DNA is circular and can have thousands of copies per 
cell, given the cell type (Wallace 2010). In addition, mitochondrial DNA 
accumulates mutations at a greater rate than nuclear DNA (Schriner, Ogburn et 
al. 2000). Due to the many copies of mitochondrial DNA per cell, there is a 
threshold level of copy numbers whereby mutated mtDNA will have an effect 
(Figure 1.2). Generally, a mtDNA deletion will affect respiratory function when it 
is present at 50-60% of total mtDNA copies (i.e. 50-60% “heteroplasmy”) in a 
cell, while point mutations such as those found in mitochondrial tRNA genes 
typically must be found in 90% of the total copy number (Larsson and Clayton 
1995). Futhermore, inheritance of mtDNA is maternal, with paternal mtDNA 
being eliminated sometime before or during fertilization (Sutovsky, Moreno et al. 
1999). Transmissions from mother to offspring of point mutations in mtDNA are 
relatively common, while transmissions of deletions from maternal mtDNA are 
rare (Chinnery, DiMauro et al. 2004). The oocyte also contains approximately 
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one hundred thousand copies of mtDNA, generated from a small pool of mtDNA 
(Jenuth, Peterson et al. 1996). All this combines to give mitochondrial genetics 
a non-Mendelian mode of inheritance, as mitochondrial genes are passed down 
maternally and the state of heteroplasmy plays a role in whether a certain 
genetic phenotype is presented at all.  
One would expect that mitochondrial genome replication and transcription 
would bear many similarities to bacteria, given its eubacterial origin. However, 
the system and proteins used to replicate mitochondrial DNA are an 
evolutionary patchwork. Many of the proteins involved in replication and 
transcription of mtDNA such as POLRMT, POLγA, and TWINKLE are actually 
of bacteriophage origin, and have conserved many of the mechanisms of that 
system. POLRMT is the RNA polymerase of the mitochondria, and contains a 
domain conserved from T7 bacteriophage to recognize promoter regions in the 
mtDNA and also can initiate DNA synthesis (Shadel and Clayton 1997, Shutt 
and Gray 2006). The DNA polymerase of mitochondria, POLγ, belongs to the 
same group of DNA polymerases as T7, the family A group (Fridlender, Fry et 
al. 1972). TWINKLE is the helicase of mtDNA, and is similar to the T7 
primase/helicase but conserves only the helicase function of T7, with no 
evidence as of yet of primase function (Spelbrink, Li et al. 2001). Despite the 
conservation of these proteins from the bacteriophage line, mtDNA replication is 
a wholly unique process. 
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Figure 1.2 Heteroplasmy and the Threshold Effect 
Mitochondrial heteroplasmy is the result of a mixed population of mutant (red 
circle) and wild-type (green circle) mitochondrial DNA within a mitochondrial 
population. In the case of a low level of heteroplasmy, mutant mtDNA will 
have no effect on mitochondrial function (green mitochondrion). However, 
due to the tendency of mutant mtDNA to proliferate more quickly than wild-
type mtDNA, mutant mtDNA becomes more prevalent and subsequently 
affects mitochondrial function (red mitochondrion). This is known as the 
“threshold effect” (Stewart and Chinnery 2015). 
Wild-type
mtDNA
Mutant
mtDNA
Threshold
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Figure 1.3 Strand Displacement Model 
OH  (origin of heavy strand) where mtDNA replication begins in the strand 
displacement model. Replication proceeds until the OL (origin of light strand) 
site, where replication temporarily stalls while the replication machinery 
assembles and begins processing from the OL to begin lagging strand 
synthesis. (B) Minimal replisome required for mtDNA replication. Twinkle and 
Top2β unwind DNA and mtSSB binds to ssDNA to allow POLγ to begin 
replicating from POLRMT primers (Falkenberg, Larsson et al. 2007). 
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While there are competing models for mtDNA replication, one model that has 
gained prominence is a classical model known as the strand displacement 
model of replication (Hudson and Chinnery 2006). The strand displacement 
model proposes that mtDNA replication is continuous on each strand, with 
replication initiating from the “heavy”-strand of mtDNA (OH) (Figure 1.3), 
displacing the parent heavy-strand as the new DNA is synthesized. The 
parental H-strand is protected by the mitochondrial single strand binding protein 
(mtSSB), which is bacterial in origin, in keeping with the theme of the crazy-quilt 
nature of mitochondrial DNA replication. Synthesis continues for two-thirds of 
the length of mtDNA until it is halted by the “light”-strand origin (OL), forming a 
triple-stranded intermediate known as the D-loop (Clayton 1991). There, a 
stem-loop structure forms and recruits POLRMT, which primes the OL for POLγ 
to begin lagging-strand synthesis. The mtSSB serves to protect the H-strand 
and also prevent aberrant synthesis from sites outside of the OL, due to the low 
specificity of POLRMT (Miralles Fuste, Shi et al. 2014). Once the two daughter 
strands have been produced, the ends of the mtDNA are ligated into circular 
DNA and superhelical turns are introduced. Also present is a DNA gyrase 
known as Top2β, which prevents the parental and daughter strains of mtDNA 
from concatenating (Zhang, Zhang et al. 2014). After the mtDNA has been 
replicated, it must be packaged into a structure known as a nucleoid. The 
nucleoid acts as a unit of inheritance in the mitochondria, being divided and 
distributed across mitochondria as they fission and fuse. Recently, single 
mtDNA molecules have been shown to be packaged into nucleoids (Kukat, 
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Davies et al. 2015) and while they lack histones, mitochondrial proteins fill the 
same role. Namely, TFAM is abundantly bound to mtDNA at intervals of ~40 bp 
and TFAM levels have been shown to affect the copy numbers of mtDNA in a 
cell (Takamatsu, Umeda et al. 2002, Alam, Kanki et al. 2003, Kaufman, Durisic 
et al. 2007). Other proteins involved in mtDNA maintenance are also found in 
the nucleoid, such as mtSSB and TWINKLE. Surprisingly, mtDNA was also 
found to bind with mitochondrial membrane associated proteins ANT-1 and 
prohibitin (Bogenhagen, Wang et al. 2003, Wang and Bogenhagen 2006, 
Bogenhagen, Rousseau et al. 2008). This suggested that mtDNA was localized 
to the membrane when packaged in nucleoids. Recalling the CORR hypothesis, 
this localization of mtDNA fits as this positions the mtDNA and its gene products 
to quickly respond to any changes in oxygen consumption by the nearby ETC.  
Transcription in the mitochondrial genetic system is also distinct from the 
nuclear system, due to the mosaic origins of the proteins involved in 
mitochondrial transcription, and a notable feature of mitochondrial transcription 
is the number of transcriptional proteins that also have another function within 
the mitochondria (Figure 1.4). The basal machinery for transcriptions consists of 
the RNA polymerase POLRMT, mitochondrial transcription factor B (TFB), and 
TFAM, which has a dual role in mtDNA packaging and transcription initiation 
(Kukat and Larsson 2013). POLRMT also has a dual role, acting as a primase 
for mitochondrial DNA replication and as an RNA polymerase for transcription. 
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POLRMT’s origins as a bacteriophage protein has already been discussed but 
worth noting is that much of the protein’s C-terminal region is conserved from 
the bacteriophage, and the method of promoter recognition is identical to that of 
the bacteriophage T7 RNA polymerase, as both use a specificity loop region 
that inserts into the DNA major groove to recognize promoter sequences 
(Cheetham and Steitz 2000, Schubot, Chen et al. 2001). Mitochondrial  
transcription factor B belongs to a family of rRNA methyltransferases and 
originates from the mitochondrial endosymbiont, and also has a dual role in 
methylating 16S rRNA (Falkenberg, Gaspari et al. 2002). POLRMT requires 
DNA to be unwound to recognize promoter sequences, and the current model 
proposes that TFAM unwinds DNA, while TFB binds to and stabilizes single-
stranded DNA, allowing POLRMT to function and initiate transcription 
(Falkenberg, Larsson et al. 2007). It has been proposed recently that replication 
and transcription is an either/or proposition in the mitochondria, and would go 
some way to explaining why a protein like POLRMT functions in both replication 
and transcription (Agaronyan, Morozov et al. 2015). 
When transcription is initiated, transcription proceeds from the heavy strand 
promoter (HSP) and the light strand promoter (LSP). In animals, the 
polycistronic transcripts of each strand containing mRNA, rRNA, and tRNA  
 15
 
Figure 1.4  mtDNA transcription 
Transcription begins when TFAM binds to mtDNA and unwinds DNA to allow 
for TFB2M to bind to Heavy strand promoter (HSP) or Light strand Promoter 
(LSP) and recruits POLRMT to HSP or LSP to begin transcription (Litonin, 
Sologub et al. 2010). 
 
LSP HSP
TFAM TFAM
Ori-H
Ori-L
TFB2M
POLRMT
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genes are punctuated at with the tRNA genes (Ojala, Montoya et al. 1981). 
These tRNA genes are believed to act as signals to be processed by the RNase  
P complex at the 5’ end of the tRNA gene and by the RNase Z complex at the 
3’ end (Hallberg and Larsson 2014). After this initial processing, mature 
mitochondrial transcripts look very different from transcripts processed in the 
nucleus. Mitochondrial transcripts often lack 5’ UTR, as in the case of the ND6 
gene, or otherwise have very short 5’ UTRs. 3’ UTRs are also absent in 
transcripts of many mitochondrial genes. Furthermore, mitochondrial mRNA’s 
lack the 7’ methylguanosine cap, a modification located on the 5’ end of mRNA 
transcripts that is required for translation of all nuclear mRNA transcripts in 
protozoan and metazoan organisms (Grohmann, Amairic et al. 1978, Cowling 
2009).  
Mitochondrial translation is also distinct from translation of nuclear proteins. In 
the nuclear genetic system, there are two forms of methionine tRNA (tRNAM), 
one for initiation of translation, and another to be used in elongation of the 
protein. Mitochondrion, however, have only one form of tRNAM that is used in 
both, with a formylation modification serving to differentiate between the initiator 
and elongator tRNAM (Tucker, Hershman et al. 2011). The composition of 
mitochondrial ribosomes also differs from those of ribosomes in the cytosol,  
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Figure 1.5 Protein Translocation into the mitochondrial matrix 
99% of proteins are imported into mitochondria. The Translocase of the Outer 
Membrane (TOM) (orange) recognizes mitochondrial preproteins via the Tom20 
component and passes the preprotein through the Tom40 channel. The 
preprotein then passes to the TIM channel (Tim23, blue) where it is pulled 
through channel by the PAM (protein assisted motor) by mitochondrial Hsp70 
(green) in a membrane potential and ATP-dependent manner. The 
presequence is then cleaved by the mitochondrial processing peptidase (MPP) 
(Chacinska, Koehler et al. 2009). 
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with rRNA comprising 25-30% of the ribosome as opposed to nearly 60% in the 
cytosolic ribosome (Hallberg and Larsson 2014). This ribosome composition 
closely resembles those of bacteriophage ribosomes, rather than the bacterial 
ribosomes that one would expect mitochondrial ribosomes be similar to given 
mitochondria’s eubacteria origins (Gray 2012). The actual synthesis of 
mitochondrial proteins, however, proceeds much like that of synthesis of 
proteins in the cytosol, with factors for initiation, elongation, and termination 
(Christian and Spremulli 2012). 
While the mitochondrial genome has its own genetic system to produce its 
gene products, the proteins made by the mammalian mtDNA comprise only 
about 1% of the mitochondrial proteome. The other 99% of proteins located in 
the mitochondria are encoded in the nucleus and produced in the cytosol 
(Chacinska, Koehler et al. 2009). Since the mitochondrion is a double-
membrane enclosed organelle known as the outer and inner mitochondrial 
membrane (OMM and IMM), proteins produced in the cytosol require a channel 
to be imported into the mitochondria. This channel, a complex of proteins 
known as the translocase of the outer/inner membrane (TOM/TIM channel) 
transport unfolded proteins through the outer and inner membranes of the 
organelle (Figure 1.5). This transport is dependent on the membrane potential 
(ΔΨ) generated by the ETC and ATP production (Chacinska, Koehler et al. 
2009). Proteins targeted to the mitochondria can contain different signals 
directing their final localization in the cell, but mitochondrial proteins directed to 
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the mitochondrial matrix contain an N-terminal presequence for targeting to 
mitochondria. The presequence is in the form of an amphipathic helix, 
containing positive residues on one side of the helix, and hydrophobic residues 
on the other face of the helix (von Heijne 1986, von Heijne, Steppuhn et al. 
1989). The positive residues target the protein to the overall negative charge of  
mitochondria that is a result of the pumping of protons out of the mitochondrial 
matrix, and the hydrophobic residues bind to a component of the TOM channel, 
Tom20 (Saitoh, Igura et al. 2007). Once bound to the TOM complex, the 
protein is passed through the main channel of the TOM, a β-barrel protein 
called Tom40 (Ahting, Thieffry et al. 2001). The protein is then passed to the 
TIM complex, and pulled through the Tim23 channel protein by the 
presequence translocase-associated motor (PAM) (Chacinska, Koehler et al. 
2009). This complex is comprised of the chaperone mitochondrial heat shock 
protein 70 (mtHsp70), which binds to the unfolded  
protein and imports it through a combined mechanism of ratcheting a pulling 
the protein in through cycles of ATP hydrolysis (Krayl, Lim et al. 2007).  Once 
the protein is in the matrix of the mitochondria, the mitochondrial processing 
peptidase (MPP) cleaves off the presequence so the protein can fold properly 
(Luciano and Geli 1996)  
1.4 Mitochondria: More than just energy production 
While much of the mitochondria’s genetic system is focused on producing and 
maintaining the electron transport chain’s function, the mitochondrion is also a 
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platform for other vital cellular functions. Iron-sulfur cluster biogenesis is in fact 
the only mitochondrial process that is indispensible for life (Lill and Muhlenhoff 
2008). Iron-sulfur clusters are small-inorganic molecules used as cofactors in a 
wide variety of cellular processes, from respiration, to DNA repair, and amino 
acid metabolism (Schagger and Pfeiffer 2000). Iron-sulfur (Fe-S) biogenesis 
begins in the mitochondria, facilitated by a complex known as the mitochondrial 
assembly machinery which consists of 17 proteins, and matured in the cytosol 
by the cytosolic iron-sulfur assembly complex (CIA) (Balk and Lill 2004) (Figure 
1.6). Iron is imported in through the Mrs3-Mrs4 channel, which is dependent on 
the proton motive force generated by the electron transport chain. Iron and 
sulfur are combined in the mitochondria and reduced using electrons received 
from NAD(P)H, the cluster is then either inserted into mitochondrial proteins or 
shuttled to the cytosol for further processing (Lill and Muhlenhoff 2008). The 
iron-sulfur clusters are vital for heme synthesis, and are cofactors in proteins of 
the electron transport chain complexes I-III, as well as many other proteins with 
a diverse array of functions in the cell (Lill, Hoffmann et al. 2012). 
Besides the synthesis of iron-sulfur clusters, the mitochondrion is also the 
source of many metabolic intermediates that are used by the cell during growth. 
The tricarboxcylic acid cycle (TCA) produces many of these intermediates. For 
example, citrate is produced by the TCA in the mitochondria and shuttled into 
the cytosol, where enzymes convert it into the small molecule acetyl-CoA which  
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Figure 1.6  Essential Mitochondrial Products 
Iron-Sulfur cluster production, Lipid biosynthesis, Calcium storage, and shuttling 
of TCA cycle products for use in other cellular processes such as acetylation. 
The proton motive force generated by oxidative phosphorylation is used to 
import molecules such as Iron (Fe2+) and Calcium (Ca2+). Iron is used to 
generate Iron-Sulfur clusters [2Fe-2S] which are then used in mitochondrial 
proteins or exported out of the mitochondria in the form of [4Fe-4S] to be used in 
enzymes involved in many different processes such as DNA repair(Lill and 
Muhlenhoff 2008). Mitochondria act as Ca2+ storage and regulate Ca2+ signaling 
by sequestering away excess Ca2+(Rizzuto, De Stefani et al. 2012). Lipid 
synthesis also takes place on the mitochondrial membrane and is tightly linked to 
the endoplasmic reticulum. CDP-DAG is a precursor to cardiolipin, a lipid that 
plays many roles in the mitochondria. Phosphotidylserine (PS) is a precursor of 
phosphotidylethanolamine (PE) that is synthesized in mitochondria and exported 
to be used throughout the cell(Osman, Voelker et al. 2011). Intermediates of the 
TCA cycle are also used to synthesize various macromolecules in the cell, 
notably Acetyl-CoA is used in protein acetylation (Wellen and Thompson 2012). 
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is used for the acetylation of proteins in the nucleus and cytosol. Acetylation is a 
protein modification used in many applications by the cell, and often causes 
widespread changes in gene expression, through histone modification to use 
one example (Wellen and Thompson 2012). Acetyl-CoA is also an important 
precursor for fatty-acid synthesis (Morrish, Noonan et al. 2010). 
Mitochondria have also long been recognized to play an important role in 
calcium handling in the cell. Although calcium is primarily stored in the 
endoplasmic reticulum (ER), mitochondria is also an important store for calcium 
and thus helps to regulate the concentration of calcium in the cytosol. 
Mitochondria also use Ca2+ for intramitochondrial signaling (Rizzuto, De Stefani 
et al. 2012). Calcium, a positively charged molecule, is drawn to the overall 
negative charge of the mitochondria, an example of the chemiosmotic gradient 
caused by the pumping of protons out of the mitochondria matrix by the ETC 
(Figure 1.6). Mitochondria are often located near calcium channels such as 
ryanodine-sensitive channels and facilitate proper function of these receptors by 
continuously removing calcium from the cytosol, providing a positive feedback 
for continued calcium transport (Szalai, Csordas et al. 2000). Once inside 
mitochondria, Ca2+ can influence oxidative phosphorylation rate as it interacts 
with several TCA cycle enzymes, notably pyruvate, α-ketoglutarate, and 
isocitrate–dehydrogenases (Forstner, Jabbal et al. 1979, Hansford 1994, 
Missale, Nash et al. 1998). This increases the amount of NADH produced by 
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the cycle and drives electron flow through the respiratory chain (Jouaville, 
Pinton et al. 1999). 
In addition to the gradient that drives calcium into mitochondria, the proximity of 
the ER to mitochondria also facilitates the transport of calcium into the 
mitochondria. These domains of close association of the ER with mitochondria 
are known as the mitochondria-associated-membrane (MAM) of the ER. These 
contacts are <200 nm apart and seem to be mediated by proteins located on 
both the mitochondria and ER (Rizzuto, Pinton et al. 1998). In yeast, this protein 
complex is known as the Endoplasmic Reticulum Mitochondria Encounter 
Structure (ERMES) (Murley and Nunnari 2016). While a similar complex does 
not seem to exist in mammals, several proteins have been identified as 
important for tethering between the mitochondria and the ER, notably the 
protein mitofusin2 (Mfn2) (de Brito and Scorrano 2008). Calcium signaling is not 
the only role for the MAM; it is also the primary site of lipid biosynthesis in the 
mitochondria (Osman, Voelker et al. 2011). There, fatty acids such as 
phosphoethanolamine (PE) are synthesized by coordination of the ER and 
mitochondria and exported to be used by organelles throughout the cell 
(Voelker 1990). Another important lipid that is produced in mitochondria is the 
glycerophospholipid cardiolipin. Cardiolipin is a non-bilayer forming lipid with a 
conical shape, as opposed to the cylindrical shape of most phospholipids (Ortiz, 
Killian et al. 1999). Cardiolipin is crucial for many mitochondrial processes, from 
providing the curvature found in the cristae of mitochondria, to helping to form 
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microdomains where proteins can cluster in the inner membrane of 
mitochondria, in particular the proteins of the electron transport chain as 
cardiolipin has been shown to be required for the formation of the  ETC 
(Pfeiffer, Gohil et al. 2003). Other pathways requiring cardiolipin include fusion 
of mitochondrial membranes, protein translocation across the mitochondrial 
membrane, and apoptosis (Osman, Voelker et al. 2011) (Figure 1.6). 
Mitochondria also have crucial roles in signaling, most notably in programmed 
cell death. The mitochondrial-mediated caspase activation pathway consists of 
the interaction of anti- and pro-apoptotic Bcl-2 family proteins. Bcl-2 and other 
anti-apoptotic proteins bind the pro-apoptotic proteins and prevent pro-apoptotic 
downstream signaling. Pro-apoptotic signals increase the expression of the pro-
apoptotic proteins Bax and other BH3-only proteins, which bind to the anti-
apoptotic proteins and allow Bax and Bid to oligomerize and initiate 
permeabilization of the mitochondrial outer membrane and release of the 
electron transport chain cofactor cytochrome c, activating the caspase cascade 
that leads to apoptosis of the cell through assembly of the apoptosome (Xiong, 
Mu et al. 2014). The mitochondrial pathway also plays a role in other forms of 
apoptosis, as inhibition of mitochondrial pathway proteins such as Bmf-2 can 
inhibit death-receptor mediated apoptosis (Hitomi, Christofferson et al. 2008) 
and receptor-mediated necrosis (necroptosis) (Ben-Ari, Pappo et al. 2007). 
However, apoptosis is only one signaling cascade in which mitochondria plays 
a pivotal role. 
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Recently, the role of mitochondria in innate and adaptive immunity has been 
more greatly appreciated. The innate immune system can recognize 
extracellular mtDNA and N-formyl peptides as damage associated molecular 
patterns (DAMPs) through Toll-like Receptors (TLR) and activate production of 
cytokines (Weinberg, Sena et al. 2015). Mitochondria also act in anti-viral 
defense through the RIG-1/MAVS pathway (Kawai, Takahashi et al. 2005). 
RIG-1 can bind viral RNA, which exposes the proteins CARD domains, which 
then bind to ubiquitin chains associated with MAVS proteins. This allows MAVS 
to oligomerize and signal the NF-κβ transcription factor (Hou, Sun et al. 2011). 
The mitochondria also affect immunity through changes in metabolism. Innate 
immune cells such as macrophages use either glycolytic or oxidative 
phosphorylation after maturation to M1 or M2 phenotype respectively 
(Haschemi, Kosma et al. 2012). Dendritic cells also undergo changes in 
metabolism after activation, and a subset of dendritic cells known as tolerogenic 
DCs use fatty acid oxidation for energy primarily (Krawczyk, Holowka et al. 
2010, Ibrahim, Nguyen et al. 2012). Adaptive immune cells also undergo 
metabolism changes during activation, as naïve T cells that differentiate into 
regulatory T cells (Tregs) require fatty acid oxidation while naïve T cells that 
differentiate into helper IL-17 T cells (Th17) increase glycolytic flux (Michalek, 
Gerriets et al. 2011). Memory T cells rely on fatty acid oxidation and show an 
increased spare respiratory capacity compared to activated or naive T cells 
(Pearce, Walsh et al. 2009, van der Windt, Everts et al. 2012). In B cells, 
mitochondrial ROS is required for antibody production in mature B cells 
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(Wheeler and Defranco 2012). In all, mitochondria function in immune cells is 
adjusted to suit the needs of that particular immune cell type. When the immune 
cells require mitochondria to synthesize metabolites for cellular growth, there is 
a shift to glycolytic metabolism. When the immune cell is requires maximum 
energy production, mitochondria are shifted primarily to oxidative 
phosphorylation or fatty acid oxidation. 
1.5 Mitochondria: The Basis for Myriad Diseases 
1.5.1 Introduction 
Mitochondrial defects affect a wide range of cellular processes, resulting in a 
wide variety of diseases. The most common diseases which have mitochondrial 
dysfunction present include neurodegenerative disorders, cardiomyopathies, 
metabolic syndrome, cancer, and obesity. In addition, mitochondrial disorders 
can manifest in any organ, at any age, depending on whether the mutations are 
autosomal, inherited from the X chromosome, or from the maternal line 
(Nunnari and Suomalainen 2012). Further proof of mitochondria’s importance in 
multiple processes is that many of the common mitochondrial mutations have a 
pleiotropic effect. This is due partially to heteroplasmy of mtDNA, the particular 
mix of wild-type and mutated mtDNA (Stewart and Chinnery 2015). As stated 
before, depending on the degree of heteroplasmy, high or low, mtDNA 
mutations can present as a more severe or less severe phenotype respectively 
(Wallace and Chalkia 2013). 
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1.5.2 Role of mtDNA Heteroplasmy in Mitochondrial Myopathies  
A common type of mitochondrial mutation is mutations located in the 
mitochondrial tRNA coding genes. tRNALeu in particular often contains a 
nt3243A>G mutation that can result in many different diseases depending on 
the level of heteroplasmy in the cell. High heteroplasmy is associated with 
mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes 
(MELAS). Low heteroplasmy of the mutation results in deafness and diabetes 
(Goto, Nonaka et al. 1990, van den Ouweland, Lemkes et al. 1992).  
Similarly, mtDNA protein coding gene ATPase6 mutations with high 
heteroplasmy lead to pigment retinopathy, ataxia, and neuropathy in adults, 
while the same mutation with low heteroplasmy leads to inherited Leigh 
syndrome in infants (Holt, Harding et al. 1990, Tatuch, Christodoulou et al. 
1992). Defects in complex I lead to atrophy of optic nerves when manifesting in 
adults and subacute necrotizing encephalopathy in infants (Wallace, Singh et 
al. 1988). As reactive oxygen species (ROS) is mainly produced by the 
respiratory complexes I and III, defects in these complexes often lead to 
aberrant ROS signaling. Leber’s hereditary optic neuropathy (LHON) is caused 
by mutations in mtDNA encoded complex I subunits which affect electron 
transfer to ubiquinone (Patsi, Kervinen et al. 2008).  
1.5.3 Mitochondrial Myopathies and Mutations of Nuclear Encoded 
Mitochondrial Genes 
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While many mitochondrially encoded genetic mutations result in various 
diseases, nuclear-encoded mitochondrial genes can underlie mitochondrial 
disease as well. For example, the majority of complex I defects found in 
patients derive from the nuclear-encoded genes of complex I (Ugalde, Janssen 
et al. 2004). Most pathogenic mutations of complex I are located in the highly 
conserved core of the complex (Yano 2002). While the exact effect of many of 
these mutations is unknown, studies of lower organisms have shown that 
complex I mutants can affect everything from electron transfer (Kerscher, 
Kashani-Poor et al. 2001) to complex I’s association with complex III (Ugalde, 
Janssen et al. 2004), which is necessary for complex I stability(Calvaruso, 
Willems et al. 2012). 
As one would imagine, mutations in any of the core mtDNA replisome proteins 
cause major mitochondrial dysfunction, and many of the mutations in nuclear-
encoded genes such as POLG and TWINKLE have similar phenotypes. Both 
POLG and TWINKLE mutations can result in progressive external 
opthalmoplegia (PEO) (Spelbrink, Li et al. 2001, Longley, Clark et al. 2006). 
Characteristics of PEO include peripheral eye muscle weakening 
(ophthalmoparesis), muscle wasting, neurological and neuromuscular defects. 
A study found that a mouse model containing a Twinkle mutation found in 
patients with PEO reconstituted many of the symptoms of the disease. These 
“Deletor” mice accumulated mtDNA deletions and showed respiratory 
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deficiencies in skeletal muscle, cerebellar and hippocampal neurons 
(Tyynismaa, Sembongi et al. 2004).  
1.5.4 Mitochondrial Dysfunction and Cancer Cells 
Cancer cells and mitochondria dysfunction have long been linked, first in the 
description of the Warburg effect in cancer cells (Koppenol, Bounds et al. 
2011). The Warburg effect describes a phenomenon in cancer cells where 
glucose  uptaken by cancer cells is fermented into lactic acid despite the ready 
availability of oxygen. While Warburg initially proposed that this phenomenon 
was due to mitochondrial dysfunction, the reality of how mitochondrial 
dysfunction interacts with cancer biology has been shown to be more 
complicated than that hypothesis. Mitochondrial function is required for cancer 
cell viability, and depletion of functional mitochondria has been shown to impair 
tumor cell growth (Weinberg, Hamanaka et al. 2010). However, rather than 
oxidative phosphorylation, mitochondria are shifted to produce macromolecules 
for the cancer cell to use for cell proliferation (Vander Heiden, Cantley et al. 
2009). Mutations in TCA cycle genes have been shown to result in many 
different cancers, in particular the isocitrate dehydrogenase-1 (IDH1) has been 
shown to be a tumor suppressor, as IDH1 mutations found in gliomas (Yan, 
Parsons et al. 2009). 
Mitochondrial DNA mutations are also associated with tumor growth, as many 
different types of cancers have been shown to accumulate mtDNA mutations as 
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they grow and some tumors contain homoplasmic mtDNA mutations (Polyak, Li 
et al. 1998, Petros, Baumann et al. 2005). These mutations can affect electron 
transport chain efficiency, and increase the production of ROS by the 
mitochondria (Ishikawa, Takenaga et al. 2008, Ralph, Rodriguez-Enriquez et al. 
2010). Further evidence that mtDNA mutations drive cancer formation have 
shown that efficient mitochondrial function is tumor suppressive in some cases 
(Santidrian, Matsuno-Yagi et al. 2013)  
 1.6 Cellular Responses To Mitochondrial Dysfunction 
 
As mitochondria are responsible for many essential cellular functions and as 
mitochondrial dysfunction results in pleiotropic diseases, maintenance of 
mitochondrial homeostasis is critical. Given the importance of this function, 
eukaryotes have several ways of monitoring mitochondrial function. Referring 
back to the CORR hypothesis, one of the tenets of CORR is that in addition to 
mitochondria sensing changes in oxygen levels through regulation of its own 
genome, a secondary signal must come from the mitochondria that reports to 
the nucleus on the current state of the organelle population (Allen 2003). This 
mitochondria to nuclear communication can happen through several pathways. 
Some signals that convey mitochondrial status to the nucleus include calcium, 
ROS, import efficiency, or energy production levels (Topf, Wrobel et al. 2016) 
(Error! Reference source not found.) 
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Figure 1.7  Mitochondrial Retrogade Signals 
Shown are retrograde signals that facilitate communication between the 
mitochondria and nucleus. Mitochondrial stress can cause altered levels of 
Calcium and ROS, and act as signals to the nucleus to activate stress 
responsive genes that restore mitochondrial function. Protein import can also be 
affected by mitochondrial stress, as mitochondrial dysfunction can affect 
oxidative phosphorylation, which drives the proton motive force and ATP 
production that fuels mitochondrial protein import. A slowdown in import can 
then signal to the nucleus mitochondrial stress, in C. elegans through the 
transcription factor ATFS-1. 
 
ROS
Calcium  Protein Import
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In yeast, mitochondria use a system of signaling known as the retrograde 
response (RTG). Mitochondrial stress caused by mtDNA depletion activates the 
transcription factors Rtg1 and Rtg3 by the sensor of mitochondrial stress Rtg2 
via an unknown mechanism. Rtg1 and Rtg3 are phosphorylated and 
sequestered from the nucleus in the absence of mitochondrial stress. During 
stress, Rtg2 is activated and Rtg1 and Rtg3 is dephosphorylated and 
translocates to the nucleus to activate the RTG response. Once the RTG is 
activated, the gene CIT2 is upregulated, a key enzyme of the glyoxylate cycle 
that is a modified tricarboxylic acid cycle that allows for alternate carbon 
sources to be used for energy. The RTG also controls TCA cycle gene 
expression once activated (Butow and Avadhani 2004).  
However, a direct homolog of the RTG pathway has not been found in 
mammals. Rather, the RTG response seems to be broken up and its role taken 
by multiple pathways. The transcription factors NRF1 and NRF2 control 
expression of the respiratory genes, VDAC, mtTFA and mtTFB (Scarpulla 
2002). Peroxisome proliferator activated receptor (PPAR) α and γ control gene 
expression of genes involved in fatty acid metabolism and β-oxidation 
(Puigserver and Spiegelman 2003). PPARγ coactivator-1 (PGC-1) controls 
mitochondrial biogenesis as well as rate of respiration in brown fat and skeletal 
muscle cells (Wu, Puigserver et al. 1999). 
As calcium regulation is an important function of mitochondria, Ca2+ can also act 
as a retrograde signal from mitochondria to the nucleus. Ca2+ is imported into 
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mitochondria due to ΔΨm, so any perturbation of ΔΨm will increase the cytosolic 
Ca2+. Sustained increase of Ca2+ cytosolic levels results in activation of the Ca2+ 
responsive phosphatase calcineurin, which results in an upregulation of genes 
involved in calcium storage and transport (Biswas, Adebanjo et al. 1999). 
Calcineurin was also shown to activate NF-κB signaling downstream of 
mitochondrial stress by dephosphorylating IkBβ, a factor that sequesters NF-κB 
in the cytosol. This dephosphorylation event disassociates IkBβ from NF-κB and 
allows NF-κB to translocate to the nucleus and activate a transcriptional 
response that includes hexokinase, ryanodine receptors, and cathepsin L 
(Butow and Avadhani 2004).  
ROS generated by the respiratory complexes are also able to signal 
mitochondrial dysfunction to the nucleus. ROS have been shown to lower the 
mitochondrial membrane potential and interfere with proper protein import 
(Wright, Terada et al. 2001). It has also been proposed that accumulation of 
oxidized proteins due to ROS exposure serves as a possible mechanism for 
NF-κB activation and upregulation of ROS-protective genes seen in 
mitochondria-stressed cells (Kriete and Mayo 2009). Additionally, ROS 
activates the Nrf2-antioxidant response element pathway (ARE), which also 
upregulates ROS protective genes (Johnson, Johnson et al. 2008). Much like 
with other pathways ROS affects, the mechanism of how elevated ROS levels 
activate these various pathways is unknown.  
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1.7 The UPRmt : A brief history 
An additional pathway in mitochondria to nuclear communication is known as 
the mitochondrial unfolded protein response (UPRmt) (Figure 1.8). This pathway 
was initially described as a way for mitochondria to maintain protein 
homeostasis in the organelle, as mitochondria are constantly importing and 
processing proteins in their unfolded state. Hoogenraad et al. initially described 
the pathway in rat hepatoma cells that had their mitochondrial DNA depleted 
through ethidium bromide (EtBr) treatment (Martinus, Garth et al. 1996). This 
group also used a mutated form of ornithine transcarbamylase (OTC), a 
mitochondrial protein that has an in-frame deletion (ΔOTC) that is imported into 
mitochondria, does not properly fold into a functional enzyme, and accumulates 
in the organelle as an unfolded protein (Zhao, Wang et al. 2002). These 
stresses were shown to upregulate mitochondrial chaperones and proteases 
such as Cpn60 (HSP60) and ClpP, which was reminiscent of the response to 
unfolded protein accumulation in the endoplasmic reticiulum, the UPRER (Ron 
and Walter 2007). The transcription factor CHOP was proposed to activate the 
UPRmt after mitochondrial stress, although the evidence for this is indirect and 
the mechanism by which CHOP senses mitochondrial stress is unknown. 
Another aspect of the mammalian UPRmt that has been proposed is the 
involvement of the double-stranded RNA-activated protein kinase (PKR) as a 
molecule that detects mitochondrial stress and signals downstream to the c-Jun 
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Figure 1.8  Mammalian Mitochondrial UPR 
While much remains unknown about the UPRmt in mammals, some studies 
have identified possible components of the UPRmt. Although no mechanism is 
known, current proposals are that accumulation of unfolded proteins or other 
stresses activates transcription of chaperones and proteases either by direct 
activation of the CHOP transcription factor, or activation of the kinase PKR. 
PKR signaling goes through the cJUN/AP1 pathway to possibly activate 
CHOP (Arnould, Michel et al. 2015). PKR is also known to phosphorylate 
eIF2α although how this might affect the UPRmt is unknown. 
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through eIF2α phosphorylation, although how the PKR kinase is activated by 
mitochondrial stress remains unknown. Exactly what the c-Jun/AP1 pathway 
can activate in response to mitochondrial stress is not known (Rath, Berger et 
al. 2012).  
Another aspect of retrograde signaling is the involvement of sirtuin proteins, a 
family of deacetylases. NAD+ is required for the function of sirtuins, and in 
particular, increased NAD+ levels activate sirtuin-1 and lead to upregulation of 
mitochondrial mRNA protein translation (Houtkooper, Mouchiroud et al. 2013). 
Another sirtuin with a role in mitochondrial stress is sirtuin-3, which responds to 
mitochondrial proteotoxic stress by inducing antioxidant genes through the 
transcription factor FOXOA3 and increasing mitochondrial turnover (Papa and 
Germain 2014).  
While there are a few proposals about the downstream effectors of 
mitochondrial stress, not much is known about the mechanism or the signal that 
communicates from the mitochondria to the nucleus to indicate the presence of 
mitochondrial stress. The aim of this thesis is to elucidate the mechanism of 
mitochondrial stress sensing in both the worm Caenorhabditis elegans and the 
mammalian system. 
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Chapter 2. Activation of UPRmt is Controlled by 
ATFS-1 via Mitochondrial Import Efficiency and 
Activates a Broad Transcriptional Response 
 
2.1 The UPRmt communicates mitochondrial stress to the nucleus by 
monitoring import efficiency 
While the initial studies of the UPRmt were carried out in mammalian cell culture, 
most of the mechanism of how the UPRmt is activated has been carried out in 
Caenorhabditis elegans. The UPRmt in C. elegans was activated by conditions 
that cause mitochondrial stress, such as depletion of mtDNA, (Yoneda, 
Benedetti et al. 2004) ETC genes (Durieux, Wolff et al. 2011), depletion of 
mitochondrial proteases (Aldridge, Horibe et al. 2007, Nargund, Pellegrino et al. 
2012), and reagents that generated a high concentration of ROS in the cell 
(Yoneda, Benedetti et al. 2004). Furthermore, worms lacking UPRmt show 
impaired growth and survival during mitochondrial stress (Haynes, Yang et al. 
2010, Nargund, Pellegrino et al. 2012). To determine how the UPRmt was being 
regulated, an RNAi screen using worms expressing a GFP reporter under the 
mitochondrial chaperone hsp-60 promoter that were exposed to mitochondrial 
stress revealed a bZIP transcription factor known as ATFS-1 that was required 
for hsp-60pr::gfp activation and thus UPRmt signaling (Haynes, Petrova et al. 
2007). What was unknown was how the transcription factor detected 
mitochondrial stress. 
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To determine how ATFS-1 regulated the UPRmt, worms were fed RNAi against 
the mitochondrial protease lon to determine if ATFS-1 was a substrate of the 
protease. Indeed, ATFS-1 accumulated in the mitochondria after depletion of 
LON protease, suggesting that ATFS-1 is imported into the mitochondrial matrix 
where it is degraded by LON protease under normal conditions. To determine if 
ATFS-1 was targeted to the mitochondria, the first 100 amino acids was N-
terminally tagged to GFP and expressed in HeLa cells. ATFS-11-100::GFP 
indeed localized to mitochondria in HeLa cells, confirming the mitochondrial 
localization of the protein (Figure 2.1). Immunoblot against fractionated HeLa 
cells confirmed ATFS-11-100::GFP was enriched in the mitochondrial fraction in a 
mature form, while the precursor form of the protein was enriched in the 
cytosolic fraction (Nargund, Pellegrino et al. 2012). This data shows that ATFS-
1 is imported into mitochondria, and its MTS is cleaved upon import. Other 
experiments in our lab found that ATFS-1 is expressed constitutively, and is 
constantly degraded by LON protease during normal conditions. This method of 
regulation echoes other stress-responsive transcription factors that are 
regulated by constant synthesis followed by turnover, such as p53 and HIF-1α 
(Haupt, Maya et al. 1997, Maxwell, Wiesener et al. 1999). 
Next, experiments were performed to determine wanted to confirm whether 
mitochondrial localization of ATFS-1 negatively regulated activation of the 
UPRmt. To test this, a construct of ATFS-1 was created that replaced the N-
terminal 23 amino acids of ATFS-1 with the protein-tag myc. This construct was 
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then expressed transgenically in worms that lacked atfs-1 expression. Indeed, 
expression of this construct in the absence of ATFS-1 was enough to activate 
hsp-60pr::gfp expression in the worm (Figure 2.2), consistent with the 
hypothesis that ATFS-1 is imported into mitochondria to prevent activation of 
the UPRmt, and blockage of ATFS-1 import is sufficient to activate the UPRmt.  
Microarrays performed by our lab found that besides the usual chaperones and 
proteases, ATFS-1 also upregulates 381 genes involved in many other 
processes, from ROS detoxification to glycolysis (Nargund, Pellegrino et al. 
2012). To further validate the direct involvement of ATFS-1 in upregulating 
these processes during mitochondrial stress, our lab performed ChIP-Seq. 
ChIP-Seq data confirmed that ATFS-1 bound to genes important for UPRmt 
activation such as hsp-60 and other genes found to be upregulated in an atfs-1 
dependent manner by microarray. There were also genes that atfs-1 appeared 
to activate indirectly, as ATFS-1 was found to not bind directly to the promoter 
regions of these genes, but according to the microarray are upregulated in an 
atfs-1 dependent manner (Nargund, Fiorese et al. 2015).  
Because ATFS-1 is a transcription factor, it must recognize a specific sequence 
in the promoter regions of genes in order to activate gene expression. Promoter 
search of genes that are activated by mitochondrial stress in an ATFS-1 
dependent manner revealed an 14-base pair element that was enriched in the 
promoter regions of UPRmt target genes (Nargund, Fiorese et al. 2015). To 
determine if that element is required for UPRmt activation, a transgene 
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containing the hsp-60pr::gfp reporter with the UPRmt element in the hsp-60 
promoter mutated was expressed in worms (hsp-60pr*::gfp). These transgenic 
worms were then subjected to mitochondrial stress and showed impaired UPRmt 
activation.  
An UPRmt element was revealed to also be located in the D-loop region of 
mtDNA as well (Nargund, Fiorese et al. 2015). This implied that ATFS-1 was 
able to bind both nuclear and mtDNA. To test this hypothesis, an EMSA was 
performed on an oligonucleotide generated containing the UPRmt element found 
in mtDNA, and incubated with recombinant ATFS-1 protein. Indeed, ATFS-1 
bound to the UPRmt Element containing oligonucleotide but not an 
oligonucleotide that contained a scrambled sequence (Figure 2.3). This data is 
consistent with ATFS-1 binding a UPRmt element in both nuclear and 
mitochondrial DNA. To confirm that ATFS-1 was binding to mtDNA during 
stress, qPCR was performed on worms with and without mitochondrial stress in 
the presence or absence of atfs-1. This data showed that during mitochondrial 
stress, atfs-1 effected a small upregulation of mtDNA transcripts, however in the 
absence of atfs-1, mtDNA transcripts were increased to 10-fold above wild-type, 
indicating that ATFS-1 was acting as a repressor of gene expression during 
stress. 
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Figure 2.1 In the absence of stress, ATFS-1 is imported into mitochondria 
A. Photomicrographs of HeLa cells expressing ATFS-11-100::GFP or GFP 
stained with MitoTracker. Scale bar, 0.25 mm (n = 3).  
B. Immunoblots of HeLa cells expressing GFP or ATFS-11-100::GFP 
following fractionation into total lysate (T), postmitochondrial 
supernatant (S) and mitochondrial pellet (M). Longer exposure of the 
ATFS-11-100::GFP panel was required due to toxicity and weak 
expression. 
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Figure 2.2 ATFS-1 is negatively regulated by mitochondrial import 
Photomicrographs of atfs-1(tm4525); hsp-60pr::gfp worms expressing wild-type 
full-length (FL) ATFS-1, ATFS-1Δ1-32.myc or ATFS-1Δ1-32.myc.ΔNLS  (n = 3). 
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2.2 ATFS-1 Regulates a Broad Transcriptional Response Including Innate 
Immunity 
 
As stated before, the role of mitochondrial biology in immunity has recently 
begun to be appreciated (Weinberg, Sena et al. 2015). While the effect of 
mitochondria on specialized immune cells has been discussed already, 
mitochondria are also a target for attack by pathogens as a way for those 
pathogens to gain a foothold in the organism for proliferation. Examples of 
such include a species of the Gram-positive bacteria Streptomyces that 
produces the mitochondrial poisons antimycin and oligomycin, which inhibit 
complex III and V respectively (Pellegrino and Haynes 2015). The pathogen 
Pseudomonas aeruginosa produces the mitochondrial complex IV inhibitor 
cyanide, a complex IV inhibitor (Pellegrino and Haynes 2015). Clearly, the 
mitochondria is an important target for pathogens as well as an organelle that 
is integral to immune signaling and function.  
Activation of the UPRmt results in a wide range of genes being activated, from 
mitochondrial chaperones and proteases typical of an unfolded protein 
response, to ROS scavengers, and interestingly, those involved in innate 
immunity (Nargund, Pellegrino et al. 2012). Other studies have shown that 
perturbation of vital cellular functions is able to activate an immune response, 
as many pathogens interfere with these vital functions (Melo and Ruvkun 
2012). Among those that activate the immune response are any that interfere 
with mitochondrial function. To test whether the UPRmt was involved in this  
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Figure 2.3 ATFS-1 binds to UPR(mt) Element located in mtDNA 
EMSA using recombinant ATFS-1 and wild-type D-loop 
oligonucleotides or D-loop oligonucleotides with the 9 base pair 
UPRmtE scrambled. Unbound oligos (black square), ATFS-1-DNA 
complex (black arrow) and the loading well (gray arrow) are 
indicated. (n = 3) 
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response, worms expressing the UPRmt reporter hsp-60pr::gfp were fed P. 
aeurginosa. After exposure to P. aeurginosa, worms showed activation of 
UPRmt in an ATFS-1 dependent manner (Pellegrino, Nargund et al. 2014). In 
addition, worms that are primed with mitochondrial stress prior to exposure to 
P. aeurginosa were more resistant to the pathogen than worms that had not 
been primed with mitochondrial stress beforehand. ATFS-1 was also required 
for this increased resistance to P. aeurginosa in these worms that had the 
UPRmt pre-activated, indicating that UPRmt activation is necessary for P. 
aeurginosa resistance in worms. 
It has also been shown that mitochondria has a role in resistance to bacterial 
infection in mammals. In particular, ROS generated by mitochondria is crucial in 
activation of the immune response to bacterial infection (Pellegrino and Haynes 
2015). Mitochondrial poisons rotenone and antimycin were able to activate the 
NRLP3 inflammosome (Traba, Kwarteng-Siaw et al. 2015). As the UPRmt 
activates innate immune genes in worms, the next question is whether 
mitochondrial stress can activate innate immune genes in the mammalian 
system. Indeed, transgenic expression of misfolded protein ΔOTC or a 
dominant negative version of mitochondrial protease AFG3L2 caused 
upregulation of innate immune genes, particularly anti-microbial peptides 
(Figure 2.4). This data is consistent with mitochondrial stresses known to 
activate the UPRmt lead to an activation of innate immune genes. 
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Figure 2.4 Mitochondrial stress results in upregulation of innate immune genes in human 
cells 
Expression levels of hBD-2, hBD-4, HD-5, and LL-37 mRNA in HEK 293T cells expressing 
dominant negative AFG3L2 (DN) or HeLa cells expressing transgenic ΔOTC (ΔOTC) or the 
respective control parent plasmids. DN cells were induced with tetracycline for 48h or ΔOTC cells 
were transfected and collected 72h later  (N=3, ± SD), * p<0.05 (Student’s t test). 
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Studies in our lab have shown that ATFS-1 is a dually localized bZIP 
transcription factor, with an MTS targeting it to the mitochondria in the absence 
of stress and an NLS that allows the protein to translocate to the nucleus if it 
accumulates in the cytosol due to mitochondrial import slowdown during 
mitochondrial stress (Figure 2.5). Once the transcription factor is localized to 
the nucleus, it activates a broad transcriptional response that upregulates 
genes from a wide range of cellular processes to repair and restore 
mitochondrial function, including genes involved in the immune response. 
ATFS-1 does this by recognition of an element known as the UPRmt element, 
which is a sequence located in the promoter region of genes that are either 
activated or repressed by ATFS-1. ATFS-1 is also still able to be imported into 
mitochondria during stress and bind to an UPRmt element in mtDNA to affect 
mtDNA expression.  
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Figure 2.5 Model of UPR(mt) Regulation in C. elegans 
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ATFS-1 is a bZIP transcription factor. In the absence of stress, ATFS-1 is 
imported into mitochondria via its MTS and degraded by the protease LON. 
During stress, ATFS-1 translocates to the nucleus due to a slowdown in 
import and activates or represses genes to rehabilitate mitochondria. ATFS-1 
also has a role in mitochondria repressing transcription. 
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Chapter 3. ATF5 as a Regulator of Mammalian 
Mitochondrial UPR 
 
3.1 Introduction 
 
Considerable evidence suggests the UPRmt is conserved in mammals where it 
was originally discovered. Expression of the mitochondrial protein ornithine 
transcarbamylase (OTC) lacking 84 amino acids rendering it unable to fold 
(∆OTC), or exposure to ethidium bromide (EtBr) which depletes mitochondrial 
DNA (mtDNA), induces transcription of mitochondrial chaperone and protease 
genes in cultured cells (Martinus, Garth et al. 1996, Zhao, Wang et al. 2002). 
Furthermore, perturbation of mitochondrial ribosomes activates a similar 
transcription response in cultured cells and mice (Wu, Williams et al. 2014, 
Moullan, Mouchiroud et al. 2015), strongly suggesting the existence of a 
homologous regulatory mechanism to that described in C.elegans. Perhaps 
most intriguing, an element in the promoters of those genes induced in a mouse 
model of mitochondrial myopathy is nearly identical to the UPRmtE to which 
ATFS-1 binds to induce chaperone and protease transcription in C. elegans 
(Tyynismaa, Carroll et al. 2010, Nargund, Fiorese et al. 2015). 
 
To identify potential regulators of a mammalian UPRmt, we searched for bZip 
proteins homologous to ATFS-1 with potential MTS. ATF4 and ATF5 had 
considerable homology within the bZip domain to ATFS-1, however ATF5 also 
had a putative, but relatively weak, MTS as determined by Mitoprot (Claros and 
Vincens 1996) (Figures 3.1 and 3.2A). Interestingly, several studies suggest a 
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role for ATF5 during mitochondrial dysfunction. A recent transcription profiling 
study from patients with autosomal dominant ataxia caused by a mutation in a 
gene encoding a mitochondrial protease had increased ATF5 transcripts 
(Mancini, Roncaglia et al. 2013), consistent with atfs-1 transcripts being induced 
in C. elegans when the orthologous mitochondrial AAA protease (spg-7) is 
impaired (Nargund, Pellegrino et al. 2012). Furthermore, mouse models of 
respiratory chain dysfunction caused by impaired mtDNA replication or a 
defective mitochondrial aspartyl-tRNA synthetase also caused induction of 
ATF5 transcripts (Tyynismaa, Carroll et al. 2010, Dogan, Pujol et al. 2014).  
 
3.2 ATF5 Complements UPRmt mutations in worms 
 
To determine if either ATF4 or ATF5 can regulate a UPRmt, the mammalian 
transcription factors were expressed in worms lacking ATFS-1. Identification of 
components that regulate the UPRmt has been facilitated by the use of 
mitochondrial chaperone transcriptional reporter C. elegans strains (Yoneda, 
Benedetti et al. 2004) (Figure 3.2B). Induction of hsp-60pr::gfp during 
mitochondrial stress requires both atfs-1 and the UPRmtE (Nargund, Fiorese et 
al. 2015). Interestingly, atfs-1-deletion worms expressing transgenic ATF5, but 
not worms expressing transgenic ATF4, were able to induce the hsp-60pr::gfp 
reporter during mitochondrial stress caused by depletion of a mitochondrial 
protein import component, timm-23, or protease, spg-7 (Figure 3.2C). In 
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Figure 3.1 – Mitochondrial targeting sequence heat map of mammalian 
bZIP proteins and BLAST homology to ATFS-1. ATFS-1 protein sequence 
was used in a protein to protein BLAST search of mammalian proteins. 
Alignment scores were taken from the BLAST search, any protein marked 
NS had no significant alignment with ATFS-1. Each bZIP N-terminal 
sequence was then entered into Mitoprot, the heat map represents the 
percentage chance the protein is imported into mitochondria. 
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Figure 3.1 Mitochondrial targeting sequence heat map of mammalian bZIP 
proteins and BLAST homology to ATFS-1 
Family Protein BLAST score Mitoprot Score
CEBPG CEBPG 16.2 17
CEBPA 27.7 12
CEBPB 28.9 6
CEBPD 27.7 2
CEBPE 15.8 1 ≥25
DDIT3 DDIT3 17.7 10 ≥10
ATF1 18.9 11 ≥5
CREB-1 15.0 2 ≥0.1
CREM 25.4 4
CREB3 30.4 0
CREB3L3 38.1 0
CREB3L4 17.3 0.4
OASISB CREB3L1 22.7 0.7
ATF6 25.0 0.7
ATF6B 28.9 6
CREBZF CREBZF 21.9 35
XBP1 XBP1 31.2 0.3
NFIL3 NFIL3 19.2 0.3
ATF2 27.7 19
ATF7 31.6 4.5
CREB5 31.2 6
JUN 33.1 18
JUNB 16.5 15
JUND 31.6 4
FOS 20.8 3
FOSB 15.4 11
FOSL1 18.5 9
FOSL2 18.5 7
ATF-3 21.9 1
JDP2 20.8 3
ATF-4 42.0 12
ATF-5 40.0 30
B-ATF 25.4 8.6
B-ATF2 21.2 0
B-ATF3 28.1 18
DBP 18.9 56
HLF 21.9 10
TEF 30.0 1
MAFF 23.9 6
MAFG 13.1 3
MAFB 23.1 5
MAF 23.9 3
MAFA NS 1
NRL NS 2
NFE2-p45 25.0 20
NFE2L1 25.0 10
NFE2L2 26.9 0
NFE2L3 26.9 59
BACH1 27.3 4
BACH 26.6 3
ATF2
SMAF
LMAF
NFE2
BACH
JUN
FOS
ATF3
ATF4
B-ATF
PAR
Mitoprot 
Score 
CEBP
CREB
OASISA
ATF6
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addition, UPRmt activation by ATF5 required the UPRmtE in the hsp-60 promoter 
(Figures 3.2D). ATF5 activation was mitochondrial stress-specific as perturbing 
endoplasmic reticulum (ER) protein folding with ero-1(RNAi) failed to activate 
hsp-60pr::gfp in transgenic ATFS-1 or ATF5 worms (Figure 3.3B), but did 
activate the ER chaperone reporter hsp-4pr::gfp (Figure 3.3C). Furthermore, 
transgenic ATF5 was unable to rescue induction of the ER UPR in worms 
lacking the ER stress-specific transcription factor XBP-1, further suggesting that 
ATF5 functions specifically during mitochondrial stress (Figure 3.3A).  
3.3 Response to Mitochondrial Stress Requires ATF5 in Mammalian Cells 
 
Analysis of all mammalian gene promoters (Bucher and Trifonov 1986) 
revealed putative UPRmtEs (Figure 3.2B) in the promoters of HSP60 (HSPD1), 
HSP10 (HSPE1), mtHSP70 (HSPA9), the mitochondrial protease LONP1, as 
well as ATF5 (data not shown) suggesting they may be regulated by ATF5. 
Exposure of HEK 293T cells to paraquat, which perturbs the respiratory chain 
causing toxic reactive oxygen (ROS) generation (Castello, Drechsel et al. 
2007), resulted in increased transcription of HSP60, mtHSP70, LONP1 and HD-
5, a secreted anti-microbial peptide (Figure 3.4B), consistent with activation of a 
UPRmt. Impressively, transcription of all four genes was significantly reduced 
when ATF5 was impaired by two different shRNAs (Figures 3.4B and 3.4C). 
Similarly, expression of ∆OTC, but not OTC (Figures 3.5B-D) caused modest 
induction of mtHSP70, HSP10, and LONP1, but not HSP60 (Figure 3.4B) 
consistent with ∆OTC being less toxic than paraquat. 
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 (A) Schematic comparing the bZip transcription factors ATFS-1 and ATF5 
including the mitochondrial targeting sequence (MTS), nuclear export sequence 
(NES) and the nuclear localization sequence (NLS). 
(B) Schematic of the hsp-60pr::gfp reporter highlighting the three UPRmt elements in 
the promoter. The mutated element used in Figure 1D is marked with an asterisk 
(*). 
(C) Photomicrographs of atfs-1(tm4525);hsp60pr::gfp  worms expressing transgenic 
ATF5, ATF4 or ATFS-1 and raised on control, timm-23, or spg-7. Scale bar, 0.5 
mm. 
(D) Photomicrographs of wildtype and atfs-1(tm4525) worms expressing either hsp-
60pr::gfp or hsp-60pr::gfp lacking a UPRmtE (*) (Figure 3.2B) raised on control or 
spg-7(RNAi). Worms in the right two panels express transgenic ATF5. Scale bar, 
0.5 mm.  
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Figure 3.2 ATF5 is able to rescue UPR(mt) 
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However, all four transcripts were reduced in ∆OTC expressing cells when 
treated with either ATF5 shRNA (Figures 3.5A-C), similar to C. elegans (Figure 
3.5A). Lastly, ATF5 transcripts were also increased during mitochondrial stress 
(Figure 3.4B and 3.5B) consistent with what has been observed for atfs-1 in 
worms (Nargund, Fiorese et al. 2015), for Atf5 in mouse models of 
mitochondrial disease (Tyynismaa, Carroll et al. 2010, Dogan, Pujol et al. 2014) 
and ATF5 in patient samples (Mancini, Roncaglia et al. 2013). Of note, mRNAs 
encoding ER resident chaperones were not induced during mitochondrial stress 
in an ATF5-dependent manner (Figures 3.3D-E) suggesting ATF5 specifically 
promotes mitochondrial protein homeostasis. 
We next sought to determine the impact of OXPHOS activity and mitochondrial 
membrane potential (∆ψ) on ATF5-dependent UPRmt activation. Interestingly, 
simultaneous inhibition of respiratory chain complexes I, III and V, which 
dissipates ∆ψ (Pfanner and Neupert 1986) induced LONP1 expression in an 
ATF5-dependent manner (Figure 3.4E) indicating that the UPRmt can be 
activated upon loss of membrane potential. However, because separate 
treatment with either piericidin (complex I), antimycin (complex III), or 
oligomycin (complex V), which does not deplete ∆ψ, also increased LONP1 
expression (Figure 3.4E), depletion of ∆ψ is not required for UPRmt activation.  
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(A) Photomicrographs of control or transgenic ATF5 expressing hsp-4pr::gfp worms, raised on  
control or xbp-1(RNAi) incubated at 20°C or 30°C. Scale bar, 0.5 mm.  
(B) Photomicrographs of atfs-1(tm4525);hsp60pr::gfp  worms expressing transgenic ATF5, ATF4 
or ATFS-1 and raised on ero-1(RNAi). Scale bar, 0.5 mm. 
(C) Photomicrographs of hsp-4pr::gfp treatd with control or ero-1(RNAi). Scale bar, 0.5 mm. 
(D-E) Expression levels of PDI, and ERO1A mRNA in control or ATF5 shRNA HEK293T cells 
treated with either (D) PQ, or (E) expressing ΔOTC (n=3 combined experiments, mean ± SEM, 
*p<0.05). 
 
 
Figure 3.3 Activation of UPR(mt) by ATF5 is specific to mitochondrial stress 
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3.4 ATF5 is Dually Localized to Mitochondria and Nucleus 
 
Because ATF5 regulates mitochondrial chaperone and protease transcription 
during mitochondrial stress similarly to ATFS-1, we hypothesized ATF5 may 
also be regulated via organelle partitioning. ATF5-dependent transcription has 
been shown to coincide with its nuclear accumulation (Monaco, Angelastro et 
al. 2007, Dalton, Lyons et al. 2013), consistent with the presence of a nuclear 
localization sequence (Figure 3.2A). Therefore, we sought to determine if ATF5 
localizes to mitochondria in the absence of mitochondrial stress. Subcellular 
fractionation in C. elegans indicated that in the absence of stress, ATF5 co-
fractionated with a mitochondrial protein (Figure 3.6A), consistent with ATF5 
being inactive in the absence of stress (Figure 3.2C). Endogenous ATF5 is 
difficult to detect in cultured mammalian cells as translation of the ATF5 
transcript is impaired by the presence of upstream open reading frames 
(uORFs) (Zhou, Palam et al. 2008), and its relatively short half-life (Uekusa, 
Namimatsu et al. 2009). To increase ATF5 expression, HeLa cells were 
cultured in the presence of a proteasome inhibitor that leads to phosphorylation 
of the translation initiation factor eIF2α and increases synthesis of proteins 
encoded by uORF containing mRNAs (Teske, Fusakio et al. 2013). Bortezomib 
treatment resulted in increased expression of ATF5, which was impaired by 
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(A) Expression levels of ATF5 mRNA in HEK 293T cells treated with vector shRNA, ATF5 
shRNA #1, or ATF5 shRNA #2 (see Experimental Procedures) (n=3, mean ± SEM, *p<0.05). 
(B) Expression levels of HSP60, mtHSP70, LONP1, HD-5, and ATF5 mRNA in control or ATF5 
shRNA HEK 293T cells with or without paraquat (PQ) (n=3, mean ± SEM, *p<0.05). 
(C) Expression levels of ATF5, HSP60, mtHSP70 and LONP1 mRNA in control or ATF5 shRNA 
#2 HEK 293T cells with or without paraquat (PQ) (n=3, mean ± SEM, p<0.05,). 
(D) Immunoblots from control or ATF5 shRNA HEK293T cells with or without oligomycin 
treatment. 
(E) Expression levels of LONP1 mRNA in control or ATF5 shRNA HEK 293T cells treated with 
oligomycin, antimycin, piericidin, or all three inhibitors (n=3, mean ± SEM, *p<0.05). 
 
 
Figure 3.4 UPR(mt) is activated in ATF5-dependent manner in HEK 293T cells 
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ATF5 shRNA (Figure 3.6B). Interestingly, ATF5 was enriched in the 
mitochondrial fraction further supporting localization of ATF5 inmitochondria in 
the absence of mitochondrial stress. Of note, we were unable to detect 
cleavage of the MTS upon import into mitochondria (Figure 3.6B), suggesting 
the MTS remains intact not unlike several other mitochondrial proteins (Amaya, 
Arakawa et al. 1988).  
Because we were only able to detect endogenous ATF5 in cultured cells upon 
proteasome inhibition (Figure 3.6B), we expressed ATF5::GFP via the CMV 
promoter in HeLa cells. Given the strong over-expression, considerable 
ATF5::GFP localized to the nucleus as expected, but ATF5::GFP also co-
localized with mitochondria (Figures 3.7A and B), unlike GFP fusion proteins 
directed to the cytosol or nucleus (Figures 3.7A and B). Unlike in cultured cells, 
ATF5 is highly expressed in mouse and human liver cells Interestingly, sucrose 
fractionation of mouse liver homogenates demonstrated co-fractionation of 
ATF5 with a mitochondrial, but not an ER-resident protein (Figure 3.6C). Given 
the difficulties in detecting ATF5 perhaps due to its low expression and short 
half-life (Zhou, Palam et al. 2008, Li, Xu et al. 2011), it has been challenging to 
observe stress dependent shifts in ATF5 localization, but because ATF5-
dependent transcription is induced during mitochondrial stress and ATF5 
localizes to mitochondria in the absence of stress, our data are consistent with 
ATF5 being regulated post-translationally similarly to (Pascual, Gomez-Lechon 
et al. 2008), ATFS-1. 
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3.5 ATF5 is required during and in recovery from Mitochondrial Stress 
Lastly, we sought to determine the role of ATF5 in protecting or maintaining 
mitochondrial function. Interestingly, in HEK 293T cells, knockdown of ATF5 
reduced basal respiration, overall respiratory capacity and maximal respiration 
(Figures 3.8A-D) suggesting a basal role for ATF5 in mitochondrial 
maintenance in these cells. ATF5 knockdown also impaired cell proliferation 
specifically in cells expressing ∆OTC (Figures 3.9A-B), further suggesting ATF5 
promotes mitochondrial function during stress. We next examined the role of 
ATF5 during the recovery from mitochondrial stress caused by depletion of 
mitochondrial genomes (mtDNAs) via EtBr exposure. mtDNA was depleted to 
~10% of normal levels in both control and ATF5 shRNA cells (Figures 3.9C ).  
Upon EtBr removal, both cell types recovered mtDNA levels at similar rates 
(Figure 3.9D), suggesting ATF5 does not affect mtDNA replication. However, 
the ATF5 shRNA cells proliferated much more slowly (Figures 3.9D and 3.9E) 
suggesting ATF5 and the regulation of mitochondrial protein homeostasis 
machinery promotes the recovery from mitochondrial stress. Furthermore, ATF5 
shRNA reduced the steady state expression of HSP60, mtHSP70, LONP1 and 
impaired cell growth (Figures 3.10A-B) in an oncocytic cell line harboring 
multiple mtDNA lesions that impair respiratory chain activity further supporting  
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(A) Immunoblots of lysates from control or ATF5 expressing atfs-1(tm4525);hsp60pr::gfp 
worms following fractionation into total lysate (T), postmitochondrial supernatant (S), and 
mitochondrial pellet (M). NDUFS3 serves as a mitochondrial marker and tubulin as a 
cytosolic marker. 
(B) Immunoblots of control or ATF5 shRNA HeLa cells treated with DMSO or Bortezomib 
and fractionated into total lysate (T), postmitochondrial supernatant (S), and mitochondrial 
pellet (M). 
(C) Immunoblot of mouse liver fractions following centrifugation on a sucrose gradient. 
Endogenous KDEL serves as an ER marker and NDUFS3 as a mitochondria marker. 
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Figure 3.5 ATF5 localizes to mitochondria in worms, humans, and mice 
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the role for ATF5-dependent transcription during mitochondrial dysfunction 
(Bonora, Porcelli et al. 2006). 
 
Combined, our data suggest that ATF5 regulates a UPRmt in mammalian cells 
that is similar to the response regulated by ATFS-1 in C. elegans. Our data 
support a model that when expressed, ATF5 localizes to mitochondria in the 
absence of stress. However, during mitochondrial stress, there is induction of 
mitochondrial protective transcripts, or a UPRmt, in an ATF5-dependent manner. 
This role is consistent with a previously established function of ATF5 as being 
anti-apoptotic by inducing BCL-2 transcription (Persengiev, Devireddy et al. 
2002) and promoting survival of a number of cancer cells including 
glioblastomas (Angelastro, Canoll et al. 2006, Sheng, Li et al. 2010), which are 
known to have mitochondrial dysfunction (Griguer and Oliva 2011). Of note, our 
work also suggests an interaction between the UPRmt and the integrated stress 
response (ISR) because increased eIF2α-phosphorylation results in preferential  
ATF5 synthesis (Zhou, Palam et al. 2008). This is consistent with several 
studies demonstrating increased eIF2α phosphorylation during mitochondrial 
dysfunction mediated by the kinases GCN2 and PERK (Hori, Ichinoda et al. 
2002, Baker, Nargund et al. 2012) and suggests an additional layer of 
regulation in addition to organelle partitioning. Our findings indicate a protective 
role for ATF5 during mitochondrial dysfunction by regulating a UPRmt 
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(A) Photomicrographs of HeLa cells expressing either ATF5::GFP, Histone 2B::GFP 
(H2B::GFP), or GFP and stained with Mitotracker. Scale bar, 0.01 mm. 
(B) Pearson Correlation Coefficient (Dunn, Kamocka et al. 2011) of co-localization of 
ATF5::GFP, Histone 2B::GFP (H2B::GFP), or GFP and MitoTracker (Figure 3C) (n=5, 
mean ± SEM, *p<0.05). 
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Figure 3.6 ATF5 is localized to mitochondria and nucleus 
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(A-B) Oxygen consumption rates (OCR) in control or ATF5 shRNA HEK 293T cells 
(n=15, mean ± SEM,*p<0.05). 
(C-D) Oxygen consumption rates (OCR) of control or ATF5 shRNA #2 HEK 293T cells 
(n=15 (control) and n=16 (ATF5sh), mean ± SEM, *p<0.05). 
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Figure 3.7 ATF5 promotes mitochondrial function 
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Figure 3.8 ATF5 promotes mitochondrial function during stress and the 
recovery from stress 
A-B) Photomicrographs (A) and doubling times (B) of control or ATF5 shRNA 
HEK 293T cells, with or without ΔOTC expression. Scale bar, 0.1 mm (n=3-7, 
mean ± SEM *p<0.05).   
(C) mtDNA quantification of control and ATF5 shRNA after 6 days of EtBr 
treatment, 4 days of withdrawal (n=3, mean ± SEM). 
(D) Time course of doubling times of control and ATF5 shRNA cells following 6 
days of mtDNA depletion by EtBr treatment (n=3, mean ± SEM, *p<0.05). 
(E) Photomicrographs of control and ATF5 shRNA cells following 6 days of 
mtDNA depletion by EtBr treatment. Scale bar, 0.1 mm. 
(F) Expression levels of ATF5 mRNA in control or ATF5 shRNA cells following 
EtBr 
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Figure 3.9  UPR(mt) is required for XTC.UC1 cell growth 
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(B) Growth curve of control or ATF5 shRNA XTC.UC1 cells (n=2, mean ± 
SEM). 
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Chapter 4. Discussion 
 
4.1 UPRmt in propagation of deleterious mtDNAs 
 
Many mitochondrial diseases are a result of mutations in mtDNA. Due to the 
heteroplasmy levels, one might think that these mutations may not manifest at 
all, but mutated mtDNA has been shown to proliferate more rapidly than would 
be expected given random segregation of mtDNA and often comes to be more 
abundant than the wild-type mtDNA in a cell (Stewart and Chinnery 2015). The 
mechanism of this faster-than-expected propagation of mutated mtDNA 
remains an unanswered question. Recently, our lab has shown that in C. 
elegans the UPRmt plays a role in the expansion of mutated mtDNA in cells (Lin, 
Schulz et al. 2016). Worms containing mutated mtDNA activate the UPRmt, and 
furthermore worms that lack atfs-1 quickly lose copy numbers of the mutated 
mtDNA. The UPRmt acts counter to the mitophagy pathway, which serves to 
clear mutated mtDNA and overexpression of the E3 Ubiquitin ligase Parkin has 
been shown to clear mutant mtDNA from cells (Suen, Narendra et al. 2010). 
Perturbing mitophagic turnover has also been shown to result in a rise in mutant 
mtDNA copy number (Lin, Schulz et al. 2016). This data shows that a possible 
way for mutated mtDNA to gain a proliferative advantage is to activate the 
UPRmt in cells, increasing biogenesis and other reparative pathways that keep 
the damaged mitochondria, and the mutated mtDNA within, from being turned 
over.  
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A natural question is whether this mechanism of mutant mtDNA proliferation is 
present in the mammalian system. As shown in Chapter 3, the mammalian 
UPRmt is regulated by the bZIP transcription factor ATF5. In order to study 
whether mutant mtDNA hijacks the UPRmt in order to proliferate, I propose to 
use various models of cybrid cells that have mutated mtDNA to study the effect 
of the UPRmt on mutant mtDNA propagation. One potential model is a 
fibrosarcoma cell line that has had mutant mtDNA inserted into it from a patient 
that has a single base-pair mutation in the COXI gene of mtDNA (Suen, 
Narendra et al. 2010). To study if the UPRmt has any effect on the proliferation 
mutant mtDNA in these cells, short-hairpin RNAi of ATF5 will be used to 
knockdown expression of that transcription factor and determine if ablation of 
UPRmt signaling in these cells reduces copy number of the mutant COXI gene. 
Metabolic changes in the form of oxidative phosphorylation or glycolytic rate will 
also be monitored. Any metabolic changes caused by UPRmt ablation would be 
studied using a Seahorse XF analyzer. 
If UPRmt inhibition causes a loss of mutant mtDNA copy number, several 
possibilities for follow-up experiments exist. Studies in the worm and elsewhere 
have shown that the fusion and fission machinery play a role in preventing 
proliferation of mutant mtDNA (Chen, Vermulst et al. 2010, Lin, Schulz et al. 
2016). The interplay of the UPRmt pathway and the fission and fusion machinery 
could be studied as it is currently unknown how those two pathways interact in 
mammals. Another potential area for study is the UPRmt role in 
 69
counterbalancing the PINK1/Parkin mitophagy pathway, as it has been shown 
that mitophagy can clear mutant mtDNA in the mammalian system (Suen, 
Narendra et al. 2010). If UPRmt inhibition causes altered metabolism in the 
cybrid cells, the interaction of the UPRmt with various metabolic pathways could 
be interrogated. 
To follow levels of mutated mtDNA in wild-type or ATF5 knockdown, restriction 
length polymorphisms that are created by the COXI mutation will be followed. 
This method is verified and has been used to track the disappearance of mutant 
mtDNA after overexpression of Parkin in these cells (Suen, Narendra et al. 
2010). One limitation of this method is that it is not quantitative, missing any 
changes in heteroplasmy that are not “all-or-nothing”. If the changes in mutant 
COXI copy number are more subtle than that, another potential method would 
be to use digital PCR to catch any change in mutant mtDNA levels (Belmonte, 
Martin et al. 2016). If no changes in copy number level are shown, it is also 
possible that a single base pair change mutant is simply too difficult to track. 
Another model of mutant mtDNA would then be used, preferably one that 
contains a large deletion that is easy to track. It is also a possibility that the 
small amount of ATF5 left after knockdown of expression is enough to maintain 
mutant mtDNA levels. In this case, CRISPR of the ATF5 gene in these cells will 
be carried out to ensure a full knock-out. 
4.2 UPRmt and other Stress Response Pathways 
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Studies of the mammalian UPRmt strongly suggest many interactions with other 
stress responses in the cell. Mitochondrial poisons are known to cause eIF2α 
phosphorylation and subsequent activation of the integrated stress response, a 
pathway that as its name suggests synthesizes responses to a wide array of 
cellular stresses (Pakos-Zebrucka, Koryga et al. 2016). We have also shown 
indirect activation of eIF2α through treatment with proteasome inhibitors in 
order to cause ATF5 accumulation and upregulation. Of particular interest 
would be to study the role of the endoplasmic reticulum and its unfolded protein 
response has in cross-communicating with the UPRmt as we have shown that 
mitochondrial stress can also activate genes involved in the UPRER and others 
have shown that endoplasmic reticulum stress can activate mitochondrial genes 
associated with the UPRmt such as LONP1 (Hori, Ichinoda et al. 2002). CHOP, 
a transcription factor proposed to play a role in UPRmt signaling, also is 
activated by the UPRER (Wang, Lawson et al. 1996, Aldridge, Horibe et al. 
2007). 
PKR has already been shown to be a potential UPRmt signaling protein (Rath, 
Berger et al. 2012), and it would be interesting to test whether any other eIF2α 
kinases also play a role in modulating UPRmt signaling. Previous studies by us 
have already shown in worms that GCN-2 signaling works in parallel to the 
UPRmt to slow-down translation of proteins in response to UPRmt activation 
(Baker, Nargund et al. 2012). GCN-2 has been shown by others to control ATF5 
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expression via eIF2α phosphorylation, a potential difference between the worm 
and mammalian UPRmt signaling pathway. 
One prominent method of communication between the ER and mitochondria is 
calcium. ER is the primary store of Ca2+ in the cell, and ER release of Ca2+ is 
uptaken by the mitochondria. Changes in cytosolic Ca2+ levels are known to 
cause stress responses that affect the mitochondria, but it is unknown what, if 
any, role the UPRmt plays in calcium signaling in the cell. Ca2+ levels could be a 
potential point of cross-talk between the ER and mitochondria, and enable 
coordination of the UPRmt and UPRER. 
In conclusion, the UPRmt is a fascinating signaling pathway that has only begun 
to be elucidated. Mitochondria’s central role in the evolution of eukaryotes 
speaks to the prominence of this organelle, evidenced by the great number of 
crucial functions carried out by the organelle besides its well-known role in 
energy production. The pleiotropic consequences of mitochondrial dysfunction 
also highlights how important the organelle is, and makes a thorough 
understanding of mitochondria biology and its many roles necessary for a 
greater understanding of all disease. The more that is elucidated about the 
UPRmt and its interactions with other processes in the cell, the more we will 
come to understand that the mitochondria is the thin-blue line between the 
order of a well-functioning cell, and the chaos of cellular dysfunction. 
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Chapter 5. Methodology 
 
Worm strains and plasmids 
 
The reporter strains hsp-60pr::gfp(zcIs9)V, hsp-4pr::gfp(zcIs4)V, atfs-1(tm4525)V 
and hsp-60pr*::gfp and RNAi feeding conditions have been described previously 
(Calfon, Zeng et al. 2002, Nargund, Pellegrino et al. 2012, Nargund, Fiorese et 
al. 2015). Induction of hsp-4pr::gfp by heat shock was performed as in (Yoneda, 
Benedetti et al. 2004). Briefly, hsp-4pr::gfp was incubated at 30°C for 1 hour to 
induce heat shock, then imaged. 
To generate the ATFS-11-100::GFP mammalian expression plasmid, a PCR 
product corresponding to the first 100 amino acids of C. elegans ATFS-1 was 
amplified from cDNA and cloned into the pEGFP-N1 plasmid. The C. elegans 
hsp-16pr::atfs-1∆1-32.myc expression plasmid was generated by PCR amplifying 
from N2 cDNA a fragment corresponding to amino acids 33-472 of ATFS-1 and 
cloning in frame and downstream of the Myc epitope sequences in the hsp-
16pr:: TAG ubl-5 plasmid (10), replacing the ubl-5 open reading frame. The hsp-
16pr::atfs-1∆1-32.myc::gfp expression plasmid was generated by ligating an ApaI-
SalI fragment containing the 3` end of atfs-1 and GFP from the atfs-1pr::atfs-
1::gfp expression plasmid (5) into similarly digested hsp-16pr::atfs-1∆1-32.myc. The 
hsp-16pr::atfs-1FL expression plasmid was generated by PCR amplification of 
the atfs-1 open reading frame from cDNA and ligating it into NheI-EcoRV 
digested hsp-16pr::atfs-1∆1-32.myc which removes the Myc sequences placing the 
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atfs-1FL sequence downstream of the hsp-16 promoter. To generate the hsp-
16pr::ATF5 expression plasmid, ATF5 cDNA was amplified and ligated into the 
hsp-16pr::atfs-1 plasmid replacing atfs-1 (Nargund, Pellegrino et al. 2012). 
Generation of hsp-16pr::ATF4 was achieved by amplifying ATF4 cDNA and 
ligating into hsp-16pr::ATF5 plasmid, replacing ATF5. The transgenic C. elegans 
lines were generated by co-injecting either the hsp-16pr::ATF5 or hsp-
16pr::ATF4 plasmid (25 ng/μl) with a myo-3pr::mCherry (60 ng/μl) marker 
plasmid, and pBluescript (65 ng/μl) into hsp-60pr::gfp; atfs-1(tm4525) generating 
multiple stable extra-chromosomal arrays. The hsp-16pr::ATF5 transgene was 
crossed into the described reporter worms. The myo-3pr::ΔOTC plasmid was 
generated by amplifying ΔOTC (Zhao, Wang et al. 2002) and ligating it into the 
myo-3pr::mCherry::ubl-5 plasmid by replacing the ubl-5 open reading frame. The 
ATF5::GFP mammalian expression plasmid was generated by amplifying ATF5 
cDNA and ligating into the EGFP-N1 plasmid (Clontech). All plasmids were 
confirmed by sequencing. 
Cell culture and plasmids 
HeLa cells were transfected with 4µg of GFP or ATFS-11-100::GFP expressing 
plasmid via Lipofectamine. The cells were imaged six hours after transfection. 
While mitochondrial localization was observed 4-10 hours following transfection, 
the cells began dying 12-15 hours posttransfection. 
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Expression of dominant-negative AFG3L2 was induced in stable HEK293 cells 
by the addition of 1µg/ml tetracycline (Ehses, Raschke et al. 2009)  and the 
cells were harvested 48 hours later. The ΔOTC expression plasmid (Zhao, 
Wang et al. 2002) was transfected into Hela cells via Lipofectamine and the 
cells were harvested after 72 hours. HeLa and HEK 293T cells were cultured in 
DMEM supplemented with 10 % FBS, 10 mM HEPES, 2 mM L-glutamine, 100 
U/ml penicillin/100 µg/ml streptomycin. ATF5-knockdown cells were generated 
through lentiviral-driven gene silencing using two different shRNAs (ATF5sh 
#1(Thermo Scientific #TRCN0000017638): 5’-AAGTCTTCCATCTGTTCCAGC-
3’; ATF5sh #2(Sigma): 5’-TGTCTTGGATACTCTGGACTT-3’) expressed by the 
pLKO.1 vector, while pLKO.1 was used as a control (Sigma). To induce 
mitochondrial stress, cells were either transfected with ΔOTC plasmid (Zhao, 
Wang et al. 2002), or treated with 400 µM paraquat for 48 hours unless stated 
otherwise. Treatment of HEK 293T cells with antimycin (Sigma), piericidin 
(Santa Cruz), and/or oligomycin (Sigma) was for 24 hours before collecting cells 
for qPCR as described below. Cellular doubling times were calculated as 
described (Chanvorachote, Luanpitpong et al. 2012). 
 
 
Electrophoretic Mobilty Shift Assay (EMSA) 
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GST-ATFS-1 was expressed in E. coli (BL21) as described (Nargund, Pellegrino et 
al. 2012). GST-ATFS-1 was affinity purified using GST-spin trap columns (GE 
Healthcare). The EMSA was performed as described (Sano, Ohyama et al. 2001). 
3 μg of purified ATFS-1 was incubated with pre-annealed IRDye700 labeled 
oligonucleotides (Integrated DNA technologies) composed of the mtDNA non-
coding region including the UPRmtE. Identical duplexed DNA with a scrambled 
UPRmtE was used to verify the specificity of the DNA-protein complex. The mixture 
was then separated on a 4% native polyacrylamide gel and imaged using an 
Odyssey Infrared Imager (Li-Cor Biosciences). EMSA was performed multiple 
times. EMSA wild type oligo F: 5'-
ATTTATATTATAAATATGATGAAGTACTAAAAAAAAGATG-3' R: 5'-
CATCTTTTTTTTAGTACTTCATCATATTTATAATATAAAT-3'. Scrambled UPRmtE 
oligo F: 5'-ATTTATATTATAAATGAAGTAATGTACTAAAAAAAAGATG-3' R: 5'-
CATCTTTTTTTTAGTACATTACTTCATTTATAATATAAAT-3'. 
RNA Isolation, qRT-PCR and Western Blots 
 
Total RNA was isolated using RNA Stat-60 (amsbio) or RNEasy Plus Mini-Kit 
(Qiagen). cDNA synthesis and qPCR was performed as described (Pellegrino, 
Nargund et al. 2014)using the following primers: hBD-2: forward 
GCCTCTTCCAGGTGTTTTTG and reverse GAGACCACAGGTGCCAATTT, 
hBD-4: forward ATGTGGTTATGGGACTGCCC and reverse 
AGCATGCATAGGTGTTGGGA, HD-5: forward TCCTTGCTGCCATTCTCCTG 
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and reverse ACTGCTTCTGGGTTGTAGCC, LL-37: forward 
GCTGGGTGATTTCTTCCGGA and reverse CCTGGGTACAAGATTCCGCA 
ATF5 forward 5’-CTGGCTCCCTATGAGGTCCTTG-3’ and reverse 5’-
GAGCTGTGAAATCAACTCGCTCAG-3’; HSP60 forward 5’-
GATGCTGTGGCCGTTACAATG-3’ and reverse 5’-
GTCAATTGACTTTGCAACAGTCACAC-3’; mtHSP70 forward 5’-
CAAGCGACAGGCTGTCACCAAC-3’ and reverse 5’-
CAACCCAGGCATCACCATTGG-3’; LONP1 forward 5’-
CATTGCCTTGAACCCTCTC-3’ and reverse 5’-ATGTCGCTCAGGTAGATGG-
3’; HD-5 forward 5’ – ACCTTGCTATCTCCTTTGCAGG-3’ and reverse 5’ – 
CGGTTCGGCAATAGCAGGTG-3’; HSP10 forward 5’-
TGGCAGGACAAGCGTTTAG-3’ and reverse 5’-
GGTTACAGTTTCAGCAGCAC-3’; PDI forward 5'- 
TGAGAACATCGTCATCGCC -3 and reverse 5’ – 
CGTTCCCCGTTGTAATCAATG – 3’; ERO1A forward 5’ - 
CAAGGGACAAGTGAAGAGAAC -3’ and reverse 5’-
 CCCCATTTCTTTTCTAACCAG -3’. And, HPRT forward 5’-
CTTTGCTGACCTGCTGGATT-3’ and reverse 5’-
TCCCCTGTTGACTGGTCATT-3’ was used as a reference gene.  
SDS-Page, western blots and mouse liver sucrose fractionation were performed 
as described (Graham 2001, Nargund, Pellegrino et al. 2012) using the 
following antibodies: OTC (Santa Cruz), Tubulin (Santa Cruz) NDUFS3 
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(Abcam), GFP (Roche), ATF5 (Zhou, Palam et al. 2008), and KDEL (Stressgen) 
and imaged on an Odyssey infrared imager (LI-COR). 
Microscopy 
 
HeLa cells were transfected using Lipofectamine 2000 (Life Technologies) with 
1 μg of GFP, Histone 2B::GFP, or ATF5::GFP expressing plasmids. The cells 
were treated with 10 μM MG-132 for 6 hours, stained with MitoTracker Red FM 
(Life) for 30 minutes prior to fixation with 4% paraformaldehyde (Fisher 
Chemicals) and incubated with primary GFP antibody (Roche) followed by 
incubation with secondary antibody AlexaFluor488 (Life). Samples were imaged 
on a Nikon Eclipse Ti. 
C. elegans images were acquired as previously described (Nargund, Pellegrino 
et al. 2012). 
 
Respiration Analysis 
 
Oxygen consumption was measured using a Seahorse Extracellular Flux 
Analyzer XFe96 as described (Yoshida, Tsutsumi et al. 2013). Analysis plates 
were coated with Corning Cell-Tak. 64,000 cells were seeded per well in 30 µl 
of XF-Media by centrifugation. After a 25 minute incubation at 37°C in an 
incubator w/o CO2, 145 µl of XF-Media was added to each well followed by 
another incubation period of 20 minutes, and then the plates were subjected to 
 78
analysis using 1 µM oligomycin, 500 nM FCCP and 1 µM rotenone/antimycin as 
indicated. Data were normalized to cell number. 
mtDNA Content  
 
DNA was extracted from 2x106 cells using phenol/chlorophorm/isoamyl alcohol 
(25:24:1) (Guo, Jiang et al. 2009) and mtDNA quantitation by qPCR was 
performed as described (Venegas and Halberg 2012) using the following 
primers: mtDNA 16S rRNA forward 5’-GCCTTCCCCCGTAAATGATA-3’ and 
reverse 5’-TTATGCGATTACCGGGCTCT-3’; nDNA β2-M forward 5’-
TGCTGTCTCCATGTTTGATGTATCT-3’ and reverse 5’-
TCTCTGCTCCCCACCTCTAAGT-3’. 
Bioinformatics 
 
Promoter search was performed using the Signal Search Analysis Server 
program FindM using the UPRmt Element previously described (Nargund, 
Fiorese et al. 2015). BLAST analysis against the whole sequence of ATFS-1 
was done using the BLASTP 2.3.1+ program (Altschul, Wootton et al. 2005). 
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Statistics 
 
Unless stated otherwise, experiments were performed at least three times, or in 
triplicates and expressed as mean ± SEM. Bar graphs of qPCR and Seahorse 
data show one representative experiment. Group differences were assayed 
using two-tailed Student’s t test. Significance was considered when p ≤ 0.05. 
Pearson correlation coefficient was performed as described in (Dunn, Kamocka 
et al. 2011). 
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